Dr. Reddys Labs (RDY) Tops Q4 EPS by 23c

Dr. Reddys Labs (NYSE: RDY) reported Q4 EPS of $0.91, $0.23 better than the analyst estimate of $0.68. Revenue for the quarter came in at $818 million versus the consensus estimate of $728.51 million.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Dutch Bros Inc. (BROS) PT Raised to $90 at DA Davidson on Sales/Earnings Upside
• Benchmark Starts Boyd Gaming (BYD) at Buy